ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intractable disease, oncology, CUP
18 employees · est. 2015 · Seoul, Korea South
Rexahn Pharmaceuticals
TARGETING DIFFICULT TO TREAT CANCERS
7 employees · est. 2001 · Rockville, United States
Rexahn Pharmaceuticals is the older company (2015 vs 2001); ONCOCROSS Co., Ltd. is the larger of the two.
Side-by-Side Comparison
| Metric | ONCOCROSS Co., Ltd. | Rexahn Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2001 older |
| Headquarters | ||
| Headquarters | Seoul, Korea South | Rockville, United States |
| Employees | ||
| Employees | 18 larger | 7 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Medical Devices, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Corporate Round | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $18.00B | $13.60M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | AI platforms for drug discovery, Cancer treatment predictive modeling, Customized medication development, In vitro and in vivo drug analysis, Collaborative AI research initiatives | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech firms, Healthcare researchers, Oncologists, Medical data analysts | Not tracked yet |
| Taxonomy | ||
| Taxonomy | AI In Drug Discovery, Transcriptomic Database, Rare Disease Treatments, Intractable Diseases, Oncology, Pharmaceutical Partnerships, Indication Expansion, NCE Indications, Reviving Failed Compounds, Drug Combination Screening, Cancer Biomarkers, CUP Diagnostics, Clinical Risk Reduction, Cost-Effective Drug Development | Rexahn Pharmaceuticals Inc., Biopharmaceutical, Cancer, Clinical Stage, Therapeutics, Targeted Therapy, Cancer Treatment, Oncology, Product Candidates, Phase 2 Clinical Development, Drug Resistance, Toxicity, Side Effects, FDA-approved, Preclinical Development |
| Website | ||
| Website | oncocross.com | rexahn.com |
About ONCOCROSS Co., Ltd.
ONCOCROSS Co., Ltd., founded in 2015, is a South Korean biotechnology and pharmaceutical innovator leveraging AI to revolutionize drug discovery and development. Positioned at the intersection of biotechnology and pharmaceutical industries, ONCOCROSS focuses on tackling challenging problems like rar...
About Rexahn Pharmaceuticals
Rexahn Pharmaceuticals is a NY Stock Exchange listed biopharmaceutical company focusing on the development of targeted therapeutics for cancer treatment. Established in 2001, Rexahn's mission is to enhance the lives of cancer patients by creating next-generation therapies with increased efficacy and...
We will tell you when either one moves
BounceWatch watches ONCOCROSS Co., Ltd. and Rexahn Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ONCOCROSS Co., Ltd. and Rexahn Pharmaceuticals — by email.
Frequently Asked Questions
Compare ONCOCROSS Co., Ltd. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ONCOCROSS Co., Ltd. on 15 Jun 2026, and Rexahn Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
